{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:32:48Z","timestamp":1789075968265,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proteolysis-targeting chimeras (PROTACs) co-op the ubiquitin system for targeted protein degradation, creating opportunities to interrogate cellular functions of proteins through \u201cchemical knockdown\u201d. However, matched pairs of protein degraders and inhibitors, that possess high specificity and chemical complementarity, for individual components of the ubiquitin system have remained scarce. This includes reagents to modulate activity and abundance of deubiquitinases (DUBs). Here, using an integrated chemical biology approach, we explore cellular functions of the DUB USP7 as a case study by comparing inhibition and degradation in melanoma and pancreatic cancer cells. Through the synthesis of a degrader library, we identify and characterize potent USP7 PROTACs for each cancer type. Proteomic and cellular analyses reveal that selective USP7 degradation modulates both shared and distinct protein sets across both cancers without affecting cell growth. In contrast, prolonged inhibitor treatment induces USP7-independent proteomic and metabolic dysregulation, highlighting important caveats for the cellular use of hydroxypiperidine-based USP7 inhibitors. Collectively, our work provides a comprehensively characterized chemical toolbox to distinguish on-target phenotypes which will aid the understanding of USP7 in malignant diseases. More broadly, our data emphasize the importance of increased specificity via PROTAC-mediated degradation and the potential of this modality to elucidate cell-line specific functions of DUBs.<\/jats:p>","DOI":"10.1038\/s41467-026-72295-x","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:56:58Z","timestamp":1778669818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4325-3528","authenticated-orcid":false,"given":"Nikolas","family":"Klink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna A.","family":"Seier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9064-0356","authenticated-orcid":false,"given":"Bikash","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-1829","authenticated-orcid":false,"given":"Martin P.","family":"Schwalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Dorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-6059","authenticated-orcid":false,"given":"Jennifer","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-2901","authenticated-orcid":false,"given":"Markus","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-3232","authenticated-orcid":false,"given":"Farnusch","family":"Kaschani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3344-7303","authenticated-orcid":false,"given":"Johannes","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4334-221X","authenticated-orcid":false,"given":"Siska","family":"F\u00fchrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6540-8520","authenticated-orcid":false,"given":"Markus","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5503-6218","authenticated-orcid":false,"given":"Nina","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-6494","authenticated-orcid":false,"given":"Stefan","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-6335","authenticated-orcid":false,"given":"Elmar","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1651-1262","authenticated-orcid":false,"given":"Annette","family":"Paschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0974-4826","authenticated-orcid":false,"given":"Barbara M.","family":"Gr\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2767-9589","authenticated-orcid":false,"given":"Malte","family":"Gersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"72295_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","volume":"25","author":"M Hinterndorfer","year":"2025","unstructured":"Hinterndorfer, M., Spiteri, V. A., Ciulli, A. & Winter, G. E. Targeted protein degradation for cancer therapy. Nat. Rev. Cancer 25, 493\u2013516 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"72295_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-pharmtox-010715-103507","volume":"57","author":"DP Bondeson","year":"2017","unstructured":"Bondeson, D. P. & Crews, C. M. Targeted protein degradation by small molecules. Annu Rev. Pharm. Toxicol. 57, 107\u2013123 (2017).","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"72295_CR3","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","volume":"10","author":"M Zengerle","year":"2015","unstructured":"Zengerle, M., Chan, K. H. & Ciulli, A. Selective small molecule induced degradation of the BET bromodomain protein BRD4. ACS Chem. Biol. 10, 1770\u20131777 (2015).","journal-title":"ACS Chem. Biol."},{"key":"72295_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","volume":"22","author":"J Lu","year":"2015","unstructured":"Lu, J. et al. Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4. Chem. Biol. 22, 755\u2013763 (2015).","journal-title":"Chem. Biol."},{"key":"72295_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","volume":"25","author":"GM Burslem","year":"2018","unstructured":"Burslem, G. M. et al. The advantages of targeted protein degradation over inhibition: an RTK case study. Cell Chem. Biol. 25, 67\u201377 (2018).","journal-title":"Cell Chem. Biol."},{"key":"72295_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41589-020-00652-y","volume":"16","author":"B Adhikari","year":"2020","unstructured":"Adhikari, B. et al. PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. Nat. Chem. Biol. 16, 1179\u20131188 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"72295_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s42003-021-02158-2","volume":"4","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Selective targeting of non-centrosomal AURKA functions through use of a targeted protein degradation tool. Commun. Biol. 4, 640 (2021).","journal-title":"Commun. Biol."},{"key":"72295_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","volume":"20","author":"MJ Clague","year":"2019","unstructured":"Clague, M. J., Urbe, S. & Komander, D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat. Rev. Mol. Cell Biol. 20, 338\u2013352 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72295_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","volume":"82","author":"SM Lange","year":"2022","unstructured":"Lange, S. M., Armstrong, L. A. & Kulathu, Y. Deubiquitinases: from mechanisms to their inhibition by small molecules. Mol. Cell 82, 15\u201329 (2022).","journal-title":"Mol. Cell"},{"key":"72295_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.chembiol.2018.10.022","volume":"26","author":"IE Wertz","year":"2019","unstructured":"Wertz, I. E. & Wang, X. From discovery to bedside: targeting the ubiquitin system. Cell Chem. Biol. 26, 156\u2013177 (2019).","journal-title":"Cell Chem. Biol."},{"key":"72295_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5763","volume":"5","author":"MS Ritorto","year":"2014","unstructured":"Ritorto, M. S. et al. Screening of DUB activity and specificity by MALDI-TOF mass spectrometry. Nat. Commun. 5, 4763 (2014).","journal-title":"Nat. Commun."},{"key":"72295_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.dnarep.2019.02.005","volume":"76","author":"A Pozhidaeva","year":"2019","unstructured":"Pozhidaeva, A. & Bezsonova, I. USP7: structure, substrate specificity, and inhibition. DNA Repair 76, 30\u201339 (2019).","journal-title":"DNA Repair"},{"key":"72295_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nsmb1067","volume":"13","author":"Y Sheng","year":"2006","unstructured":"Sheng, Y. et al. Molecular recognition of p53 and MDM2 by USP7\/HAUSP. Nat. Struct. Mol. Biol. 13, 285\u2013291 (2006).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"72295_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq7598","volume":"8","author":"A Sijm","year":"2022","unstructured":"Sijm, A. et al. USP7 regulates the ncPRC1 Polycomb axis to stimulate genomic H2AK119ub1 deposition uncoupled from H3K27me3. Sci. Adv. 8, eabq7598 (2022).","journal-title":"Sci. Adv."},{"key":"72295_CR15","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1002\/1873-3468.12471","volume":"590","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Trip12 is an E3 ubiquitin ligase for USP7\/HAUSP involved in the DNA damage response. FEBS Lett. 590, 4213\u20134222 (2016).","journal-title":"FEBS Lett."},{"key":"72295_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo0789","volume":"8","author":"XW Zhang","year":"2022","unstructured":"Zhang, X. W. et al. Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy. Sci. Adv. 8, eabo0789 (2022).","journal-title":"Sci. Adv."},{"key":"72295_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nchembio.2528","volume":"14","author":"G Gavory","year":"2018","unstructured":"Gavory, G. et al. Discovery and characterization of highly potent and selective allosteric USP7 inhibitors. Nat. Chem. Biol. 14, 118\u2013125 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"72295_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nature24006","volume":"550","author":"L Kategaya","year":"2017","unstructured":"Kategaya, L. et al. USP7 small-molecule inhibitors interfere with ubiquitin binding. Nature 550, 534\u2013538 (2017).","journal-title":"Nature"},{"key":"72295_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature24451","volume":"550","author":"AP Turnbull","year":"2017","unstructured":"Turnbull, A. P. et al. Molecular basis of USP7 inhibition by selective small-molecule inhibitors. Nature 550, 481\u2013486 (2017).","journal-title":"Nature"},{"key":"72295_CR20","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.1021\/acs.jmedchem.0c00245","volume":"63","author":"PR Leger","year":"2020","unstructured":"Leger, P. R. et al. Discovery of potent, selective, and orally bioavailable inhibitors of USP7 with in vivo antitumor activity. J. Med. Chem. 63, 5398\u20135420 (2020).","journal-title":"J. Med. Chem."},{"key":"72295_CR21","doi-asserted-by":"crossref","unstructured":"Tong, J., Watkins, J. M., Burke, J. M. & Kodadek, T. Assessing the suitability of deubiquitylases as substrates for targeted protein degradation. bioRxiv, 2025.06.13.659525 (2025).","DOI":"10.1101\/2025.06.13.659525"},{"key":"72295_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202204395","volume":"61","author":"Y Pei","year":"2022","unstructured":"Pei, Y. et al. Discovery of a potent and selective degrader for USP7. Angew. Chem. Int Ed. Engl. 61, e202204395 (2022).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"72295_CR23","doi-asserted-by":"publisher","first-page":"13197","DOI":"10.1021\/acs.jmedchem.4c01134","volume":"67","author":"M Xu","year":"2024","unstructured":"Xu, M. et al. Discovery of a highly potent, selective and efficacious USP7 degrader for the treatment of acute lymphoblastic leukemia. J. Med Chem. 67, 13197\u201313216 (2024).","journal-title":"J. Med Chem."},{"key":"72295_CR24","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.1039\/D2CC02094G","volume":"58","author":"A Murgai","year":"2022","unstructured":"Murgai, A. et al. Targeting the deubiquitinase USP7 for degradation with PROTACs. Chem. Commun. 58, 8858\u20138861 (2022).","journal-title":"Chem. Commun."},{"key":"72295_CR25","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1038\/s44318-025-00517-x","volume":"44","author":"M Reinders","year":"2025","unstructured":"Reinders, M. et al. ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains. EMBO J. 44, 5086\u20135111 (2025).","journal-title":"EMBO J."},{"key":"72295_CR26","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/s41418-023-01180-7","volume":"30","author":"J Yi","year":"2023","unstructured":"Yi, J. et al. Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1. Cell Death Differ. 30, 1799\u20131810 (2023).","journal-title":"Cell Death Differ."},{"key":"72295_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chembiol.2020.09.005","volume":"28","author":"JW Bushman","year":"2021","unstructured":"Bushman, J. W. et al. Proteomics-based identification of DUB substrates using selective inhibitors. Cell Chem. Biol. 28, 78\u201387.e3 (2021).","journal-title":"Cell Chem. Biol."},{"key":"72295_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25454-1","volume":"12","author":"M Steger","year":"2021","unstructured":"Steger, M. et al. Time-resolved in vivo ubiquitinome profiling by DIA-MS reveals USP7 targets on a proteome-wide scale. Nat. Commun. 12, 5399 (2021).","journal-title":"Nat. Commun."},{"key":"72295_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62076-x","volume":"10","author":"NJ Schauer","year":"2020","unstructured":"Schauer, N. J. et al. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism. Sci. Rep. 10, 5324 (2020).","journal-title":"Sci. Rep."},{"key":"72295_CR30","doi-asserted-by":"publisher","first-page":"1349509","DOI":"10.3389\/fmolb.2024.1349509","volume":"11","author":"M Campos Alonso","year":"2024","unstructured":"Campos Alonso, M. & Knobeloch, K. P. In the moonlight: non-catalytic functions of ubiquitin and ubiquitin-like proteases. Front Mol. Biosci. 11, 1349509 (2024).","journal-title":"Front Mol. Biosci."},{"key":"72295_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05962-6","volume":"22","author":"J Gu","year":"2024","unstructured":"Gu, J. et al. Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. J. Transl. Med. 22, 1135 (2024).","journal-title":"J. Transl. Med."},{"key":"72295_CR32","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s10637-020-00951-0","volume":"38","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance. Invest N. Drugs 38, 1707\u20131716 (2020).","journal-title":"Invest N. Drugs"},{"key":"72295_CR33","first-page":"25","volume":"97","author":"ME Desmond","year":"1986","unstructured":"Desmond, M. E. & Schoenwolf, G. C. Evaluation of the roles of intrinsic and extrinsic factors in occlusion of the spinal neurocoel during rapid brain enlargement in the chick embryo. J. Embryol. Exp. Morphol. 97, 25\u201346 (1986).","journal-title":"J. Embryol. Exp. Morphol."},{"key":"72295_CR34","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1111\/jcmm.16834","volume":"25","author":"M Xiang","year":"2021","unstructured":"Xiang, M. et al. Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo. J. Cell Mol. Med. 25, 9228\u20139240 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"72295_CR35","doi-asserted-by":"publisher","first-page":"111396","DOI":"10.1016\/j.celrep.2022.111396","volume":"40","author":"L Granieri","year":"2022","unstructured":"Granieri, L. et al. Targeting the USP7\/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC\/LSD1 inhibitors. Cell Rep. 40, 111396 (2022).","journal-title":"Cell Rep."},{"key":"72295_CR36","doi-asserted-by":"publisher","first-page":"650165","DOI":"10.3389\/fonc.2021.650165","volume":"11","author":"L Gao","year":"2021","unstructured":"Gao, L. et al. Proteome analysis of USP7 substrates revealed its role in melanoma through PI3K\/Akt\/FOXO and AMPK Pathways. Front. Oncol. 11, 650165 (2021).","journal-title":"Front. Oncol."},{"key":"72295_CR37","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.jid.2025.03.021","volume":"145","author":"L Su","year":"2025","unstructured":"Su, L. et al. Selective USP7 inhibition synergizes with MEK1\/2 inhibitor to enhance immune responses and potentiate anti-PD-1 therapy in NRAS-mutant melanoma. J. Invest. Dermatol. 145, 2549\u201325611 (2025).","journal-title":"J. Invest. Dermatol."},{"key":"72295_CR38","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/nchembio.2486","volume":"13","author":"EL Weisberg","year":"2017","unstructured":"Weisberg, E. L. et al. Inhibition of USP10 induces degradation of oncogenic FLT3. Nat. Chem. Biol. 13, 1207\u20131215 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"72295_CR39","doi-asserted-by":"publisher","first-page":"15711","DOI":"10.1021\/acs.jmedchem.5c00718","volume":"68","author":"S Wittenburg","year":"2025","unstructured":"Wittenburg, S. et al. Enhancing solubility in VHL-based PROTACs: optimized USP7 degraders for improved developability. J. Med Chem. 68, 15711\u201315737 (2025).","journal-title":"J. Med Chem."},{"key":"72295_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","volume":"22","author":"D Chauhan","year":"2012","unstructured":"Chauhan, D. et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22, 345\u2013358 (2012).","journal-title":"Cancer Cell"},{"key":"72295_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ijch.201900167","volume":"60","author":"SL Buchwald","year":"2020","unstructured":"Buchwald, S. L. & Hartwig, J. F. In praise of basic research as a vehicle to practical applications: palladium-catalyzed coupling to form carbon-nitrogen bonds. Isr. J. Chem. 60, 177\u2013179 (2020).","journal-title":"Isr. J. Chem."},{"key":"72295_CR42","doi-asserted-by":"publisher","first-page":"8216","DOI":"10.1039\/D2CS00387B","volume":"51","author":"CJ Diehl","year":"2022","unstructured":"Diehl, C. J. & Ciulli, A. Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders. Chem. Soc. Rev. 51, 8216\u20138257 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"72295_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13312","volume":"7","author":"J Frost","year":"2016","unstructured":"Frost, J. et al. Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition. Nat. Commun. 7, 13312 (2016).","journal-title":"Nat. Commun."},{"key":"72295_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.jmedchem.8b01631","volume":"62","author":"X Han","year":"2019","unstructured":"Han, X. et al. Discovery of ARD-69 as a highly potent proteolysis targeting chimera (PROTAC) degrader of androgen receptor (AR) for the treatment of prostate cancer. J. Med. Chem. 62, 941\u2013964 (2019).","journal-title":"J. Med. Chem."},{"key":"72295_CR45","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1091\/mbc.e11-08-0668","volume":"23","author":"S Urbe","year":"2012","unstructured":"Urbe, S. et al. Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions. Mol. Biol. Cell 23, 1095\u20131103 (2012).","journal-title":"Mol. Biol. Cell"},{"key":"72295_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/acschembio.7b00549","volume":"13","author":"MK Schwinn","year":"2018","unstructured":"Schwinn, M. K. et al. CRISPR-mediated tagging of endogenous proteins with a luminescent peptide. ACS Chem. Biol. 13, 467\u2013474 (2018).","journal-title":"ACS Chem. Biol."},{"key":"72295_CR47","doi-asserted-by":"publisher","first-page":"e202508916","DOI":"10.1002\/anie.202508916","volume":"64","author":"S Fuhrer","year":"2025","unstructured":"Fuhrer, S. et al. Small molecule-induced alterations of protein polyubiquitination revealed by mass-spectrometric ubiquitome analysis. Angew. Chem. Int Ed. Engl. 64, e202508916 (2025).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"72295_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acschembio.9b00092","volume":"14","author":"MJ Roy","year":"2019","unstructured":"Roy, M. J. et al. SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate. ACS Chem. Biol. 14, 361\u2013368 (2019).","journal-title":"ACS Chem. Biol."},{"key":"72295_CR49","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/s41596-024-00979-z","volume":"19","author":"MP Schwalm","year":"2024","unstructured":"Schwalm, M. P., Saxena, K., Muller, S. & Knapp, S. Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cells. Nat. Protoc. 19, 2317\u20132357 (2024).","journal-title":"Nat. Protoc."},{"key":"72295_CR50","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.mcpro.2024.100800","volume":"23","author":"K Frohlich","year":"2024","unstructured":"Frohlich, K. et al. Data-independent acquisition: a milestone and prospect in clinical mass spectrometry-based proteomics. Mol. Cell Proteom. 23, 100800 (2024).","journal-title":"Mol. Cell Proteom."},{"key":"72295_CR51","first-page":"1016","volume":"36","author":"L Nie","year":"2022","unstructured":"Nie, L. et al. USP7 substrates identified by proteomics analysis reveal the specificity of USP7. Genes Dev. 36, 1016\u20131030 (2022).","journal-title":"Genes Dev."},{"key":"72295_CR52","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1016\/j.molcel.2025.06.027","volume":"85","author":"D Chakraborty","year":"2025","unstructured":"Chakraborty, D. et al. Nucleosomes specify co-factor access to p53. Mol. Cell 85, 2919\u20132936.e12 (2025).","journal-title":"Mol. Cell"},{"key":"72295_CR53","doi-asserted-by":"publisher","first-page":"e1007193","DOI":"10.1371\/journal.pgen.1007193","volume":"14","author":"B Stielow","year":"2018","unstructured":"Stielow, B., Finkernagel, F., Stiewe, T., Nist, A. & Suske, G. MGA, L3MBTL2 and E2F6 determine genomic binding of the non-canonical Polycomb repressive complex PRC1.6. PLoS Genet. 14, e1007193 (2018).","journal-title":"PLoS Genet."},{"key":"72295_CR54","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1182\/blood-2014-03-559591","volume":"124","author":"JF Fecteau","year":"2014","unstructured":"Fecteau, J. F. et al. Lenalidomide inhibits the proliferation of CLL cells via a cereblon\/p21(WAF1\/Cip1)-dependent mechanism independent of functional p53. Blood 124, 1637\u20131644 (2014).","journal-title":"Blood"},{"key":"72295_CR55","doi-asserted-by":"crossref","unstructured":"Schenk, P. et al Global analysis of cancer cell responses to USP9X inhibition. bioRxiv, 2025.06.18.660475 (2025).","DOI":"10.1101\/2025.06.18.660475"},{"key":"72295_CR56","doi-asserted-by":"publisher","first-page":"102435","DOI":"10.1016\/j.isci.2021.102435","volume":"24","author":"H Maat","year":"2021","unstructured":"Maat, H. et al. The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia. iScience 24, 102435 (2021).","journal-title":"iScience"},{"key":"72295_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003863","volume":"10","author":"B Thier","year":"2022","unstructured":"Thier, B. et al. Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity. J. Immunother. Cancer 10, e003863 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"72295_CR58","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00428-003-0784-4","volume":"442","author":"B Sipos","year":"2003","unstructured":"Sipos, B. et al. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch. 442, 444\u2013452 (2003).","journal-title":"Virchows Arch."},{"key":"72295_CR59","doi-asserted-by":"publisher","first-page":"e202318849","DOI":"10.1002\/anie.202318849","volume":"63","author":"M Schmidt","year":"2024","unstructured":"Schmidt, M. et al. N-cyanopiperazines as specific covalent inhibitors of the deubiquitinating enzyme UCHL1. Angew. Chem. Int Ed. Engl. 63, e202318849 (2024).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"72295_CR60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"72295_CR61","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 27, 491\u2013499 (2017).","journal-title":"Genome Res."},{"key":"72295_CR62","doi-asserted-by":"publisher","first-page":"e1003118","DOI":"10.1371\/journal.pcbi.1003118","volume":"9","author":"M Lawrence","year":"2013","unstructured":"Lawrence, M. et al. Software for computing and annotating genomic ranges. PLoS Comput. Biol. 9, e1003118 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"72295_CR63","doi-asserted-by":"crossref","unstructured":"Chen, Y., Chen, L., Lun, A. T. L., Baldoni, P. L. & Smyth, G. K. EdgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets. Nucleic Acids Res. 53, 018 (2025).","DOI":"10.1093\/nar\/gkaf018"},{"key":"72295_CR64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","volume":"14","author":"CS Hughes","year":"2019","unstructured":"Hughes, C. S. et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat. Protoc. 14, 68\u201385 (2019).","journal-title":"Nat. Protoc."},{"key":"72295_CR65","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906 (2007).","journal-title":"Nat. Protoc."},{"key":"72295_CR66","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30, 918\u2013920 (2012).","journal-title":"Nat. Biotechnol."},{"key":"72295_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"72295_CR68","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteom. 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"72295_CR69","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"72295_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"72295_CR71","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794\u20131805 (2011).","journal-title":"J. Proteome Res."},{"key":"72295_CR72","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72295-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72295-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72295-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:04:01Z","timestamp":1778717041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72295-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72295"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72295-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4331"}}